Altimmune Inc (NASDAQ:ALT)

1.59
Delayed Data
As of Feb 21
 +0.1101 / +7.44%
Today’s Change
1.34
Today|||52-Week Range
10.80
-20.10%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close1.48
Today’s open1.49
Day’s range1.46 - 1.60
Volume303,377
Average volume (3 months)204,259
Market cap$23.2M
Data as of 3:59pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.1
Price/Sales40.80
Price/Book0.52

Competitors

 Today’s
change
Today’s
% change
--Molecular Templates ...+0.27+3.10%
NVIVInVivo Therapeutics ...+0.01+1.27%
HSGXHistogenics Corp-0.07-2.55%
AZRXAzurRx BioPharma Inc+0.02+0.70%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts